These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33806305)

  • 41. Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase.
    Pantouris G; Mowat CG
    Biochem Biophys Res Commun; 2014 Jan; 443(1):28-31. PubMed ID: 24269239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developing reliable classification of dual IDO1/TDO inhibitors using data fusion and majority voting.
    Ghaemi Z; Asadollahi-Baboli M
    J Biomol Struct Dyn; 2023 Nov; ():1-9. PubMed ID: 37921776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.
    Hjortsø MD; Larsen SK; Kongsted P; Met Ö; Frøsig TM; Andersen GH; Ahmad SM; Svane IM; Becker JC; Straten PT; Andersen MH
    Oncoimmunology; 2015 Jan; 4(1):e968480. PubMed ID: 25949861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Wang XX; Sun SY; Dong QQ; Wu XX; Tang W; Xing YQ
    Medchemcomm; 2019 Oct; 10(10):1740-1754. PubMed ID: 32055299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of oxindoles as promising inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Srivastava GN; Trivedi V; Manna D
    Medchemcomm; 2017 Aug; 8(8):1640-1654. PubMed ID: 30108875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-1β increases expression of tryptophan 2,3-dioxygenase and stimulates tryptophan catabolism in endometrioma stromal cells.
    Urata Y; Koga K; Hirota Y; Akiyama I; Izumi G; Takamura M; Nagai M; Harada M; Hirata T; Yoshino O; Kawana K; Fujii T; Osuga Y
    Am J Reprod Immunol; 2014 Nov; 72(5):496-503. PubMed ID: 24974860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
    Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function.
    Elbers F; Woite C; Antoni V; Stein S; Funakoshi H; Nakamura T; Schares G; Däubener W; Eller SK
    Mediators Inflamm; 2016; 2016():1638916. PubMed ID: 27563172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.
    Lanz TV; Williams SK; Stojic A; Iwantscheff S; Sonner JK; Grabitz C; Becker S; Böhler LI; Mohapatra SR; Sahm F; Küblbeck G; Nakamura T; Funakoshi H; Opitz CA; Wick W; Diem R; Platten M
    Sci Rep; 2017 Jan; 7():41271. PubMed ID: 28117398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting tryptophan availability to tumors: the answer to immune escape?
    Badawy AA
    Immunol Cell Biol; 2018 Nov; 96(10):1026-1034. PubMed ID: 29888434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937.
    Hoffmann D; Pilotte L; Stroobant V; Van den Eynde BJ
    Int J Tryptophan Res; 2019; 12():1178646919891736. PubMed ID: 31903023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases.
    Zhou Q; Shi Y; Chen C; Wu F; Chen Z
    Ann Transl Med; 2021 Jan; 9(2):174. PubMed ID: 33569476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular evolution of bacterial indoleamine 2,3-dioxygenase.
    Yuasa HJ; Ushigoe A; Ball HJ
    Gene; 2011 Oct; 485(1):22-31. PubMed ID: 21689736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas.
    Sonner JK; Deumelandt K; Ott M; Thomé CM; Rauschenbach KJ; Schulz S; Munteanu B; Mohapatra S; Adam I; Hofer AC; Feuerer M; Opitz CA; Hopf C; Wick W; Platten M
    Oncoimmunology; 2016; 5(12):e1240858. PubMed ID: 28123877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The autoimmune response elicited by mouse hepatitis virus (MHV-A59) infection is modulated by liver tryptophan-2,3-dioxygenase (TDO).
    Duhalde Vega M; Aparicio JL; Mandour MF; Retegui LA
    Immunol Lett; 2020 Jan; 217():25-30. PubMed ID: 31726186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors.
    Parr BT; Pastor R; Sellers BD; Pei Z; Jaipuri FA; Castanedo GM; Gazzard L; Kumar S; Li X; Liu W; Mendonca R; Pavana RK; Potturi H; Shao C; Velvadapu V; Waldo JP; Wu G; Yuen PW; Zhang Z; Zhang Y; Harris SF; Oh AJ; DiPasquale A; Dement K; La H; Goon L; Gustafson A; VanderPorten EC; Mautino MR; Liu Y
    ACS Med Chem Lett; 2020 Apr; 11(4):541-549. PubMed ID: 32292562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.